Wikisage, the free encyclopedia of the second generation, is digital heritage
Memantine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Memantine is a non competitive NMDA-R antagonist, with serotoninergic 5HT3-R dopaminergic | Memantine is a non competitive NMDA-R antagonist, with serotoninergic 5HT3-R dopaminergic D<sub>2</sub>-R and cholinergic maCHh-R and nACh-R antagonism, used to control acquired pendular nystagmus | ||
<ref>Soto E and Rosario Vega [[2010]] Neuropharmacology of vestibular system disorders Current Neuropharmacology 8: 26-40 | <ref>Soto E and Rosario Vega [[2010]] Neuropharmacology of vestibular system disorders Current Neuropharmacology 8: 26-40 | ||
</ref> | </ref> | ||
Revision as of 15:19, 2 May 2019
Memantine is a non competitive NMDA-R antagonist, with serotoninergic 5HT3-R dopaminergic D2-R and cholinergic maCHh-R and nACh-R antagonism, used to control acquired pendular nystagmus [1]
